Table 1. Summary of clinical & laboratory data for different groups.
| Healthy | Anemic | CKD | ||
|---|---|---|---|---|
| # of cases | 22 | 7 | 30 | |
| Male | 15 | 0 | 15 | |
| Female | 7 | 7 | 15 | |
| Age (yrs) | 50.4±15.3 | 44.5±10.3 | 61.6±10.4 | |
| Laboratory findings | eGFR (ml/min per 1.73 m2) / CKD stage | 91.7±12.8 | 90.3±12.4 | Stage 2 (n = 10); 3 (n = 10); 4 (n = 7); 5 (n = 3) |
| Hb (g/dl) | — | 11.1±0.69 | 12.6±1.8 | |
| Urinary protein (mg/mg UCr) | — | — | 0.83±0.9 | |
| Systolic Blood pressure (mm Hg) | — | 122.2±.34.0 | 130.7±25.6 | |
| Diastolic Blood pressure (mm Hg) | — | 72.4±14.7 | 70.7±15.5 | |
| Primary Diseases | — | — | — | Diabetes (n = 11); Hypertension (n = 7); interstitial nephritis (n = 3); lupus nephritis (n = 2); IGA nephropathy (n = 1); membranous glomerulopathy (n = 1); cardio-renal syndrome (n = 1); unknown (n = 4) |
| Medications | — | — | — | ACEi/ARBs (n = 11); Ferrous sulfate (n = 7); Feraheme (n = 1); ESA (n = 7) |